Study guide

10.3 Call Recording & Third-Party Marketing Organization (TPMO) Disclaimers

AHIP Medicare Certification Exam

Track your progress as you read

Finished sections get a check mark.

1 Introduction

1.1 About the AHIP Medicare Certification Exam 1.2 How to Use This Study Guide

2 Chapter 2: Medicare Program Fundamentals

2.1 What Medicare Is: Program Structure & How Parts A–D Fit Together 2.2 Medicare Part A — Hospital Insurance 2.3 Medicare Part B — Medical Insurance 2.4 Medicare Eligibility Rules (Age 65, Disability, ESRD, ALS)

3 Chapter 3: Medicare Enrollment Periods

3.1 Initial Enrollment Period (IEP) 3.2 Annual Enrollment Period (AEP): October 15 – December 7 3.3 Medicare Advantage Open Enrollment Period (MA OEP): January 1 – March 31 3.4 Special Enrollment Periods (SEPs) & Qualifying Life Events 3.5 Late Enrollment Penalties (Part A, Part B, Part D)

4 Chapter 4: Medigap & Coordination of Coverage

4.1 Medigap (Medicare Supplement) Basics & Guaranteed Issue Rights 4.2 Dual Eligibility & Medicare Savings Programs 4.3 How Original Medicare, MA, Part D & Medigap Interact

5 Chapter 5: Medicare Advantage Plan Types

5.1 Medicare Advantage (Part C) Overview: How MA Differs from Original Medicare 5.2 HMO & HMO-POS Plans 5.3 PPO Plans 5.4 PFFS Plans (Private Fee-for-Service) 5.5 MSA Plans (Medicare Medical Savings Accounts) 5.6 Cost Plans & Employer Group Waiver Plans (EGWPs)

6 Chapter 6: Special Needs Plans & MA Plan Design

6.1 Special Needs Plans (SNPs) Overview 6.2 D-SNP — Dual-Eligible Special Needs Plans 6.3 C-SNP & I-SNP — Chronic Condition & Institutional Special Needs Plans 6.4 MA Benefits, MOOP & Supplemental Benefits 6.5 MA Star Ratings & Plan Quality

7 Chapter 7: Part D Structure & the 2026 Redesign

7.1 Part D Overview & Eligibility 7.2 Formularies & Drug Tiers 7.3 The 2026 Part D Benefit Redesign ($2,100 OOP Cap, $615 Max Deductible, Catastrophic Phase) 7.4 Medicare Prescription Payment Plan (Drug-Cost Smoothing)

8 Chapter 8: Part D Costs, Assistance & Appeals

8.1 Low-Income Subsidy (LIS) / Extra Help 8.2 Part D Late Enrollment Penalty & Creditable Coverage 8.3 Coverage Determinations, Exceptions & Appeals

9 Chapter 9: CMS Marketing Rules & Scope of Appointment

9.1 CMS Medicare Communications & Marketing Guidelines (MCMG) Overview 9.2 Scope of Appointment (SOA): the 48-Hour Rule & Exceptions 9.3 Permitted vs. Prohibited Marketing & Sales Activities 9.4 Marketing Events vs. Educational Events

10 Chapter 10: Enrollment & Disclosure Requirements

10.1 The Pre-Enrollment Checklist (PEC) 10.2 Enrollment Procedures & Application Requirements 10.3 Call Recording & Third-Party Marketing Organization (TPMO) Disclaimers 10.4 Agent & Broker Compensation Rules

11 Chapter 11: Marketing Conduct & Oversight

11.1 Cross-Selling Restrictions & Nominal Gift Value Rules 11.2 Marketing to Vulnerable Populations & Non-Discrimination in Sales 11.3 Website, Social Media & Advertising Compliance 11.4 Complaint Tracking Module (CTM) & Agent Oversight

12 Chapter 12: Understanding Fraud, Waste & Abuse

12.1 Defining Fraud, Waste & Abuse (and the Difference Between Them) 12.2 The False Claims Act 12.3 The Anti-Kickback Statute

13 Chapter 13: Compliance Laws & Screening

13.1 The Stark Law (Physician Self-Referral) 13.2 HIPAA Privacy & Security Basics 13.3 The OIG Exclusion List & Sanctioned-Provider Screening

14 Chapter 14: Reporting, Compliance Programs & Consequences

14.1 Detecting & Reporting FWA 14.2 Compliance Program Requirements (Seven Core Elements) & Non-Discrimination Training 14.3 Consequences & Corrective Action Plans

10.3 Call Recording & Third-Party Marketing Organization (TPMO) Disclaimers

Key Takeaways Explain This Topic AI

A TPMO is any organization or individual compensated to perform lead-generation, marketing, sales, or enrollment functions for an MA/Part D plan — including independent agents and brokers.

Calls anywhere within the 'chain of enrollment' with a Medicare prospect or beneficiary must be recorded in their entirety and retained for a minimum of 10 years.

The TPMO disclaimer must be read verbally within the first minute of a sales call and displayed in writing on marketing materials, emails, chats, and websites.

A disclaimer read accurately but after the first minute is still a compliance violation — timing is enforced as strictly as wording.

The TPMO disclaimer (how many organizations/plans an agent represents) is a separate requirement from the Scope of Appointment (which product types may be discussed).

Last updated: July 2026

Why This Topic Matters

Call recording and the Third-Party Marketing Organization (TPMO) disclaimer are among the most literal, rule-based items on the AHIP final — CMS wrote specific numbers (a retention period, a timing window) into federal regulation, and AHIP tests those numbers directly. This is a section where memorizing the exact rule pays off more than understanding a broad concept, because the exam questions are often "what is the retention period" or "when must the disclaimer be read" rather than open-ended scenario analysis.

What Is a TPMO?

A Third-Party Marketing Organization (TPMO) is any organization or individual that is compensated — directly or indirectly — by a Medicare Advantage or Part D plan to perform lead generation, marketing, sales, or enrollment functions on the plan's behalf. Under 42 CFR §422.2260 and §423.2260, this reaches far beyond big call-center vendors: it explicitly includes independent agents, brokers, field marketing organizations (FMOs), and agencies — essentially, anyone in the sales chain between the plan and the beneficiary who is compensated for marketing, sales, or enrollment activity. If you are a licensed agent selling MA or Part D plans and receiving commission, you are functioning as (or through) a TPMO for compliance purposes, and the recording and disclaimer rules below apply to you directly.

Call Recording Requirements

CMS requires TPMOs to record, in their entirety, all calls with prospective and current Medicare beneficiaries that fall anywhere within the "chain of enrollment" — from the very first phone contact with a prospect through the completed enrollment — for MA, MA-PD, standalone Part D (PDP), and other supplemental benefit (OSB) product sales.

  • Requirement Detail
  • What must be recorded The entire call, start to finish — not just the enrollment portion
  • Which calls Any call within the "chain of enrollment" with a Medicare prospect or current beneficiary
  • Retention period A minimum of 10 years
  • Access Recordings must be available to CMS upon request

A common misconception is that only the final "enrollment call" needs to be recorded. In reality, an initial inbound call where the beneficiary just asks about plan options — with no enrollment discussed yet — still falls inside the chain of enrollment if it eventually leads to a sale, and must be recorded and retained under the same 10-year rule.

The TPMO Disclaimer

CMS requires every TPMO to convey a standardized disclaimer to beneficiaries, both verbally on sales calls and in writing/electronically on marketing materials, print pieces, emails, chat, and consumer-facing websites that discuss or market MA/Part D plans. The disclaimer must disclose how many organizations and plans the TPMO actually represents, so a beneficiary understands they may not be seeing every option in their area.

Standard multi-plan disclaimer (agents representing multiple carriers):

"We do not offer every plan available in your area. Currently we represent [insert number] organizations which offer [insert number] products in your area. Please contact Medicare.gov, 1-800-MEDICARE, or your local State Health Insurance Program to get information on all of your options."

Simplified/anonymous web version (for general website traffic, not tied to a specific consumer):

"We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."

The single most tested detail is timing : on a sales call, the verbal disclaimer must be read to the beneficiary within the first minute of the call. Reading it later in the call — even if it is eventually read in full — is a compliance violation, because the beneficiary needs that context before substantive plan discussion begins.

TPMO Disclaimer vs. Scope of Appointment: Don't Confuse Them

The TPMO disclaimer discloses how many organizations/plans you represent ; the SOA (Chapter 9) authorizes which product types you may discuss . They are separate documents with separate purposes, and an exam question may test whether you can tell which requirement a scenario is violating.

Exam Scenario

An agent is on a recorded sales call with a beneficiary. Three minutes into the call, after discussing plan benefits at length, the agent finally reads the TPMO disclaimer in full, word-for-word, exactly as required. Has the agent satisfied the disclaimer requirement?

No. Even though the disclaimer's wording was correct and complete, it was not conveyed within the required first-minute window. The timing failure is itself the violation — CMS does not treat a late-but-accurate disclaimer as compliant, because the beneficiary made it through several minutes of substantive plan discussion without the context the disclaimer is meant to provide up front.

Takeaways

A TPMO is any organization or individual compensated to perform marketing, lead-gen, sales, or enrollment functions for an MA/Part D plan — this includes independent agents and brokers.

Calls anywhere in the chain of enrollment must be recorded in their entirety and retained for a minimum of 10 years .

The TPMO disclaimer must be read verbally within the first minute of a sales call, and displayed in writing on marketing materials, emails, chats, and websites.

A disclaimer read accurately but late in the call is still a violation — timing matters as much as wording.

The TPMO disclaimer (organization/plan count disclosure) is a different requirement from the Scope of Appointment (product-type authorization) — don't conflate the two on the exam.